期刊文献+

新生血管性青光眼的治疗进展 被引量:9

The Treatment Progress of Neovascular Glaucoma
下载PDF
导出
摘要 新生血管性青光眼(NVG)是具有严重致盲性的一种青光眼,归因于新生血管生成阻碍房水外流,通常继发于糖尿病性视网膜病变、缺血性视网膜中央静脉阻塞和眼部缺血综合征。NVG主要表现为封闭的房角,虹膜新生血管,严重的眼痛和视力通常较差以及非常高的眼压。因其病因复杂,治疗难度大,对患眼威胁甚大。尽管多年来已提出相当多的药物或手术治疗方式,但仍未找到一种可治疗大多数NVG以及预防失明的治疗方法。 Neovascular glaucoma(NVG) is a severe form of glaucoma with devastating visual outcome at- tributed to new blood vessels obstructing aqueous humor ou^ow. The most eommon diseases responsible for development of NVG are ischemic central retinal vein occlusion, diabetic retinopathy and ocular ischemic syndrome. It is characterized by iris neovascularization, a closed anterior chamber angle, and extremely high intraoculai~ pressure (lOP) with severe ocular pain and usually poor vision. Management of NVG primarily consists of controlling the high IOP by medical and/or surgical means to minimize the visual loss. Currently, a satisfactory means of treating NVG and preventing visual loss in the majority is still not found, in spite of multiple modes of medical and surgical options advocated over the years.
作者 陆庆 谢冰
出处 《医学综述》 2012年第19期3242-3244,共3页 Medical Recapitulate
关键词 新生血管性青光眼 药物治疗 手术治疗 Neovascular glaucoma Medical treatment Surgical treatment
  • 相关文献

参考文献27

  • 1Shukla D,Arora A,Hadi KM,et al.Combined central retinal arteryand vein occlusion secondary to systemic non-Hodgkin's lymphoma[J].Indian J Ophthalmol,2006,54(3):204-206. 被引量:1
  • 2Setlur VJ,Parikh JG,Rao NA.Changing causes of enucleation overthe past 60 years[J].Graefes Arch Clin Exp Ophthalmol,2010,248(4):593-597. 被引量:1
  • 3Elgin U,Berker N,Batman A.Incidence of secondary glaucoma inbehcet disease[J].J Glaucoma,2004,13(6):441-444. 被引量:1
  • 4Shields JA,Shields CL,Honavar SG,et al.Clinical variations andcomplications of Coats disease in 150 cases:the 2000 Sanford Gif-ford Memorial Lecture[J].Am J Ophthalmol,2001,131(5):561-571. 被引量:1
  • 5Atmaca LS,Batioglu F,Atmaca Sonmez P.A long-term follow-up of Eales'disease[J].Ocul Immunol Inflamm,2002,10(3):213-221. 被引量:1
  • 6Shazly TA,Latina MA.Neovascular glaucoma:etiology,diagnosisand prognosis[J].Semin Ophthalmol,2009,24(2):113-121. 被引量:1
  • 7Bhisitkul RB.Vascular endothelial growth factor biology:clinicalimplications for ocular treatments[J].Br J Ophthalmol,2006,90(12):1542-1547. 被引量:1
  • 8李娟,马晓华,毕宏生,李忠恩,潘雪梅.玻璃体腔注射Avastin辅助治疗新生血管性青光眼[J].中国实用眼科杂志,2010,28(4):378-380. 被引量:20
  • 9Konner J,Dupont J.Use of soluble recombinant decoy receptor vas-cular endothelial growth factor trap(VEGF Trap)to inhibit vascularendothelial growth factor activity[J].Clin Colorectal Cancer,2004,4(2):S81-S85. 被引量:1
  • 10Ashikari M,Tokoro M,Itaya M,et al.Suppression of laser-inducedchoroidal neovascularization by nontargeted siRNA[J].InvestOphthalmol Vis Sci,2010,51(7):3820-3824. 被引量:1

二级参考文献13

共引文献28

同被引文献54

引证文献9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部